CKD-519

· Chong Kun Dang Pharmaceutical

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for CKD-519, covering 2015-09-11 to 2018-11-06. Get the full timeline:

Most recent: Clinical Trial Update: To Assess the Safety, Efficacy and Tolerability of CKD-519, Administered With HMG-CoA Reductase Inhibitors [Phase 2]

See pricing